Hematopoietic stem cells: concepts, assays, and controversies
- PMID: 1799665
Hematopoietic stem cells: concepts, assays, and controversies
Abstract
Mature cells of the hematopoietic system, including B and T lymphocytes, have a limited life span and must be continuously replenished by differentiation from immature precursors. The stability of the hematopoietic system depends on the maintenance of a pool of pluripotent hematopoietic stem cells. During the past 30 years, the development of quantitative assays for stem cells and their progeny has led to an explosion of information concerning the stages of differentiation, regulatory factors and receptors, and characterization of surface markers. Nevertheless, there remain many controversies about the properties of cells in the stem cell compartment. The degree of heterogeneity within the stem cell compartment is unknown. The detailed mechanisms for regulation of stem cells are uncertain. Finally, the factors which control the recruitment of quiescent stem cells are unknown and controversial.
Similar articles
-
[The hematopoietic stem cell: biology and clinical applications].Pathologica. 2001 Feb;93(1):2-14. Pathologica. 2001. PMID: 11294014 Review. Italian.
-
[Hematopoietic stem cells].Therapie. 2001 Jul-Aug;56(4):379-81. Therapie. 2001. PMID: 11677857 Review. French.
-
Pegylated granulocyte colony-stimulating factor mobilizes CD34+ cells with different stem and progenitor subsets and distinct functional properties in comparison with unconjugated granulocyte colony-stimulating factor.Haematologica. 2008 Mar;93(3):347-55. doi: 10.3324/haematol.12081. Epub 2008 Feb 11. Haematologica. 2008. PMID: 18268278
-
Interleukin-11 stimulates the proliferation of human hematopoietic CD34+ and CD34+CD33-DR- cells and synergizes with stem cell factor, interleukin-3, and granulocyte-macrophage colony-stimulating factor.Exp Hematol. 1993 Dec;21(13):1668-72. Exp Hematol. 1993. PMID: 7694867
-
Differentiation of hematopoietic progenitor cells towards the myeloid and B-lymphoid lineage by hepatocyte growth factor (HGF) and thrombopoietin (TPO) together with early acting cytokines.Eur J Haematol. 2006 Aug;77(2):134-44. doi: 10.1111/j.1600-0609.2006.00673.x. Eur J Haematol. 2006. PMID: 16856909
Cited by
-
Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities.EMBO J. 1996 Oct 15;15(20):5647-58. EMBO J. 1996. PMID: 8896458 Free PMC article.
-
Concise review: Cancer stem cells and minimal residual disease.Stem Cells. 2012 Jan;30(1):89-93. doi: 10.1002/stem.769. Stem Cells. 2012. PMID: 22045578 Free PMC article. Review.
-
Dynamics of haemopoiesis across mammals.Proc Biol Sci. 2008 Oct 22;275(1649):2389-92. doi: 10.1098/rspb.2008.0506. Proc Biol Sci. 2008. PMID: 18628121 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Miscellaneous